miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression.

Published on Feb 13, 2020in Cells4.366
· DOI :10.3390/CELLS9020435
Federica Rotundo2
Estimated H-index: 2
,
Denis Cominetti14
Estimated H-index: 14
+ 7 AuthorsPaolo Gandellini25
Estimated H-index: 25
Sources
Abstract
The development of novel therapies or the improvement of currently used approaches to treat prostate cancer (PCa), the most frequently diagnosed male tumor in developed countries, is an urgent need. In this regard, the functional characterization of microRNAs, molecules shown to regulate a number of cancer-related pathways, is instrumental to their possible clinical exploitation. Here, we demonstrate the tumor-suppressive role of the so far uncharacterized miR-1272, which we found to be significantly down-modulated in PCa clinical specimens compared to normal tissues. Through a gain-of-function approach using miRNA mimics, we showed that miR-1272 supplementation in two PCa cell models (DU145 and 22Rv1) reverted the mesenchymal phenotype by affecting migratory and invasive properties, and reduced cell growth in vitro and in vivo in SCID mice. Additionally, by targeting HIP1 encoding the endocytic protein HIP1, miR-1272 balanced EGFR membrane turnover, thus affecting the downstream AKT/ERK pathways, and, ultimately, increasing PCa cell response to ionizing radiation. Overall, our results show that miR-1272 reconstitution can affect several tumor traits, thus suggesting this approach as a potential novel therapeutic strategy to be pursued for PCa, with the multiple aim of reducing tumor growth, enhancing response to radiotherapy and limiting metastatic dissemination.
📖 Papers frequently viewed together
13 Citations
9 Authors (I-Shan Hsieh, ..., Yuh Ling Chen)
160 Citations
32 Citations
References36
Newest
#1H Q Mu (WMU: Wenzhou Medical College)H-Index: 1
#2Y H He (WMU: Wenzhou Medical College)H-Index: 1
Last. Y H Chen (WMU: Wenzhou Medical College)H-Index: 1
view all 9 authors...
Background Angiogenesis is a critical biological process essential for solid cancer growth and metastasis. It has been shown that microRNAs (miRNAs) play a vital role in a variety of biological processes in cancers. However, whether miR-130b is involved in prostate cancer angiogenesis remains ill-defined.
17 CitationsSource
#1Subhayan Sur (SLU: Saint Louis University)H-Index: 11
#2Robert Steele (SLU: Saint Louis University)H-Index: 57
Last. Ratna B. Ray (SLU: Saint Louis University)H-Index: 60
view all 4 authors...
Prostate cancer is one of the most common cancers among men. Currently available therapies improve patient survival against local prostate cancer but have shown severe side effects. Advanced prostate cancer is still incurable. Studies have suggested the involvement of non-coding RNAs, especially micro-RNAs (miRNAs), in the regulation of multiple cellular events in cancer and thus several clinical trials are ongoing using miRNAs mimics or inhibitors. We previously demonstrated that miRNA-29b-3p (...
12 CitationsSource
Background Radiotherapy is one of the main treatment options for non-metastatic prostate cancer (PCa). Although treatment technical optimization has greatly improved local tumor control, a considerable fraction of patients still experience relapse due to the development of resistance. Radioresistance is a complex and still poorly understood phenomenon involving the deregulation of a variety of signaling pathways as a consequence of several genetic and epigenetic abnormalities. In this context, c...
28 CitationsSource
#1Basak Icli (Brigham and Women's Hospital)H-Index: 17
#2Winona W. Wu (Brigham and Women's Hospital)H-Index: 7
Last. Mark W. Feinberg (Brigham and Women's Hospital)H-Index: 38
view all 20 authors...
Angiogenesis is a critical process in repair of tissue injury that is regulated by a delicate balance between pro- and antiangiogenic factors. In disease states associated with impaired angiogenesi...
18 CitationsSource
#1Valentina ProfumoH-Index: 7
#2Barbara ForteH-Index: 2
Last. Paolo GandelliniH-Index: 25
view all 14 authors...
Though miR-205 function has been largely characterized, the nature of its host gene, MIR205HG, is still completely unknown. Here, we show that only lowly expressed alternatively spliced MIR205HG transcripts act as de facto pri-miRNAs, through a process that involves Drosha to prevent unfavorable splicing and directly mediate miR-205 excision. Notably, MIR205HG-specific processed transcripts revealed to be functional per se as nuclear long noncoding RNA capable of regulating differentiation of hu...
21 CitationsSource
#1Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 67
#2Kimberly D. Miller (ACS: American Cancer Society)H-Index: 28
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 3 authors...
: Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2015, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2016, were collected by the Nati...
8,491 CitationsSource
#1Teresina Laragione (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 10
#2Max Brenner (The Feinstein Institute for Medical Research)H-Index: 15
Last. Pércio S. Gulko (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 13
view all 6 authors...
Objectives While new treatments for rheumatoid arthritis (RA) have markedly improved disease control by targeting immune/inflammatory pathways, current treatments rarely induce remission, underscoring the need for therapies that target other aspects of the disease. Little is known about the regulation of disease severity and joint damage, which are major predictors of disease outcome, and might be better or complementary targets for therapy. In this study, we aimed to discover and characterise a...
6 CitationsSource
#1Jing Wang (BCM: Baylor College of Medicine)H-Index: 106
#2Suhas Vasaikar (BCM: Baylor College of Medicine)H-Index: 16
Last. Bing Zhang (BCM: Baylor College of Medicine)H-Index: 57
view all 5 authors...
Functional enrichment analysis has played a key role in the biological interpretation of high-throughput omics data. As a long-standing and widely used web application for functional enrichment analysis, WebGestalt has been constantly updated to satisfy the needs of biologists from different research areas. WebGestalt 2017 supports 12 organisms, 324 gene identifiers from various databases and technology platforms, and 150 937 functional categories from public databases and computational analyses...
526 CitationsSource
#1Rihan El BezawyH-Index: 3
#2Denis CominettiH-Index: 14
Last. Paolo GandelliniH-Index: 25
view all 12 authors...
Abstract Radiotherapy is one of the main treatment choices for non-metastatic prostate cancer (PCa), although development of radioresistance limits its effectiveness. Mounting evidence supports the ability of microRNAs to interfere with different radioresistance-associated pathways, suggesting their potential as radiosensitizers. Here, we demonstrate that reconstitution of miR-875-5p, whose expression is down-regulated in PCa clinical samples and directly correlates with that of E-cadherin, was ...
57 CitationsSource
#1Nicolas MottetH-Index: 40
#2Joaquim Bellmunt (Harvard University)H-Index: 87
Last. Philip CornfordH-Index: 27
view all 22 authors...
Abstract Objective To present a summary of the 2016 version of the European Association of Urology (EAU) - European Society for Radiotherapy & Oncology (ESTRO) - International Society of Geriatric Oncology (SIOG) Guidelines on screening, diagnosis, and local treatment with curative intent of clinically localised prostate cancer (PCa). Evidence acquisition The working panel performed a literature review of the new data (2013–2015). The guidelines were updated and the levels of evidence and/or gra...
1,813 CitationsSource
Cited By1
Newest
#1Valentina DoldiH-Index: 8
#2Rihan El BezawyH-Index: 3
Last. Nadia ZaffaroniH-Index: 66
view all 3 authors...
Prostate cancer (PCa) is the second most common tumor in men worldwide, and the fifth leading cause of male cancer-related deaths in western countries. PC is a very heterogeneous disease, meaning that optimal clinical management of individual patients is challenging. Depending on disease grade and stage, patients can be followed in active surveillance protocols or undergo surgery, radiotherapy, hormonal therapy, and chemotherapy. Although therapeutic advancements exist in both radiatiotherapy an...
Source
Prostate cancer (PCa) is the fifth cause of tumor-related deaths in man worldwide. Despite the considerable improvement in the clinical management of PCa, several limitations emerged both in the screening for early diagnosis and in the medical treatment. The use of prostate-specific antigen (PSA)-based screening resulted in patients’ overtreatment and the standard therapy of patients suffering from locally advanced/metastatic tumors (e.g., radical prostatectomy, radiotherapy, and androgen depriv...
1 CitationsSource